Payers, policy & prices: a jump on market access for canadian healthcare entrepreneurs

You will find the science determined, ok now what?

Like a startup it may be easy to pay attention to the science until signing an issue, however when you are finally all set to go to promote, have you contemplated the thing you need to become effective? Health technology assessments (HTA), prices, and dealing with payers are key stages in making certain your technology will get where it matters most –to the patients.

Like a healthcare entrepreneur within the pharmaceutical sector, you should develop technologies which are addressing an unmet need and also have the evidence required for market access. It’s also crucial that you begin considering market access before your science will get too much lower the street.

Come along at JLABS @ Toronto on June 15th to have an “Introduction to promote Access” workshop for Canadian healthcare startups. Topics include:

  • Background on every stage of market access:
           – HTA
           – Prices
           – Dealing with Payers to Secure Drug Coverage (Public & Private)
  • A much deeper dive into Public & Private Payers
  • How startups should approach & get ready for market access

Following the presentations, Simon Lee, Chief Negotiator, OPDP, Sherry O’Quinn, Managing Principal, Morse Talking to Corporation. & Debbie Milliken, Md Healthcare Talking to, MILLREED Enterprises Limited. is going to be on hands to possess 1-on-1 conferences with startup companies to go over the way they are approaching market access for his or her technology. Obtain a meeting here .

Let’s make sure that you are checking from the market access box before it’s far too late.

*Please be aware this workshop is introduced for you by Canadian experts – we won’t be discussing Market Access in other jurisdictions at the moment.


10:00 AM Registration Opens as well as networking
10:15 AM Stages of Market Access
  – Overview on all steps (HTA, PMPRB/prices, Payors, Negotiations)
In-depth look: Public Payors
In-depth look: Private Payors
11:20 AM Networking Break
11:30 AM Panel Session
12:15 PM Q&A
12:30 PM Networking Lunch
1:00 PM – 5:00PM 1-on-1 Conferences

*Companies should have requested a 1-on-one meeting in advance and become approved. The applying period ends on June fifth, 2017.

Atul Goela Director, Pharmaceutical Benefits, Sun Existence Financial read bio»
Debbie Milliken Md Healthcare Talking to, MILLREED Enterprises Limited. read bio»
Allan Miranda Reimbursement Lead Immunology and first Care, Janssen Canada read bio»
Sherry O’Quinn Managing Principal, Morse Talking to Corporation. read bio»

Conferences Company:
Simon Lee Chief Negotiator, OPDP read bio»

There’s cost-free to go to this workshop, but pre-registration is needed.

JLABS @ Toronto
661 College Ave, Suite 1300
Toronto, Ontario

Speakers’ Biographies:
Atul Goela Director, Pharmaceutical Benefits, Sun Existence Financial
Atul Goela became a member of Sun Existence Financial Canada in October 2014 like a Product Director, Pharmaceutical Benefits. He’s a key cause of the pharmaceutical strategy and demonstrates Sun Life’s overall thought leadership in this subject within his responsibilities, he participates in client conferences, presents at conferences and strengthens Sun Life’s industry relations. Just before joining Sun Existence Financial, Atul labored at Eco-friendly Shield Canada as senior pharmacy services consultant. Additionally to as being a practicing pharmacist, Atul also stayed at Shoppers Drug Mart’s mind office. The mixture of Atul’s extensive experience of the pharmacy and pharmacy benefits management arena, plays a role in Sun Life’s ongoing leadership within the pharmaceutical benefits space. Atul holds a Bs in Pharmacy in the College of Toronto.

Debbie Milliken Md Healthcare Talking to, MILLREED Enterprises Limited.
Debbie Milliken is Md Healthcare Talking to at MILLREED Enterprises Limited. She’s an authorized pharmacist using the Ontario College of Pharmacists and it has an extensive base of private and public sector experience over the healthcare sector with knowledge of areas of pharmaceuticals, patient support programs, reimbursement strategy, healthcare policy, drug evaluation. She holds a Bs degree in pharmacy in the College of Toronto and completed a certified Canadian Pharmacy Residency (ACPR) program. She’s labored in hospital, government, government agency and also the pharmaceutical industry. Debbie was the Director, Provincial Reimbursement Drug Programs at Cancer Care Ontario for six years, where she managed the province’s formulary for intravenously administered cancer medications (New Drug Funding Program). Inside the pharmaceutical industry, Debbie has labored at SmithKline Beecham, GlaxoSmithKline, and Roche and held a number of positions in sales, reimbursement, government relations, and patient programs. She’s labored using the Ontario Government along with other participating jurisdictions around the Pan-Canadian Pharmaceutical Alliance (PCPA).
Interact with Debbie:   Connect on LinkedIn

Allan F. Miranda Ph.D., Master of business administration Reimbursement Lead Immunology and first Care, Janssen Canada
Dr. Miranda accounts for HECOR and Market Access for that Immunology (REMICADE, SIMPONI, STELARA) and first Care portfolios at Janssen Canada. Allan continues to be with Janssen Canada in excess of twelve many in the current role for many years. Additionally to his experience of ACCESS, Allan held positions of growing responsibility running a business Development and Marketing at Janssen. Just before joining Janssen, Allan labored in Licensing and Business Development for PARTEQ Innovations, we’ve got the technology transfer office at Queen’s College at Kingston in addition to Biotechnology and Niche Pharmaceutical companies across Canada. Allan received his Ph.D. in Neuropharmacology from Queen’s College at Kingston and the Master of business administration from McGill College in Finance and Strategy. Allan is part of the Licensing Executive Society and ISPOR. He’s enthusiastic about getting novel health technologies towards the Canadian marketplace for the advantage of patients.

Sherry O’Quinn Managing Principal, Morse Talking to Corporation.
Sherry O’Quinn may be the Managing Principal at Morse Talking to Corporation. She focuses on helping clients comprehend the market access atmosphere and developing ways of optimize reimbursement success. Just before embarking into talking to, Sherry spent over twenty years employed in the general public healthcare sector, including 13 years using the Ontario Public Drug Programs (OPDP) where she was most lately accountable for leading the settlement of product listing contracts, and serving as the operational co-result in the pan-Canadian Pharmaceutical Alliance (pCPA). Sherry was integrally active in the development of work from the pCPA established in 2015. In her own time at OPDP she brought over 100 Ontario specific negotiations and 20 pCPA negotiations. Just before joining government, she labored at Sunnybrook Health Sciences Center like a hospital pharmacist and it has also labored in retail pharmacy and also the pharmaceutical industry.
Interact with Sherry:   Connect on LinkedIn

Simon Lee Chief Negotiator, OPDP
Simon Lee may be the Chief Negotiator for that Ontario Public Drug Programs. Simon and the passionate team represent the Ontario Public Drug Programs inside the pan-Canadian Pharmaceutical Alliance (pCPA). They accounts for leading negotiations with pharmaceutical manufacturers with respect to the pCPA, in addition to negotiations and contracting for Ontario specific contracts. Simon is really a pharmacist by training, and it has an extensive experience like a clinician both in hospital and community pharmacy practice. Just before joining the Secretary of state for Health insurance and Lengthy-Term Care, Simon held various roles and it was accountable for sales, operations, clinical programs and formulary management within the private drug plan industry.
Interact with Simon:   Connect on LinkedIn


Treating Canada's Health Care System


Sean Webb: I love this woman. She is clearly intelligent, articulate and has considered these issues from several different vantage points. However, there are some universal truths that we must acknowledge. Our species has always endured sickness, injuries and death. Science and modern medicine have done great work to reduce the suffering and restore function while extending life. But it will never be entirely eliminated. We're still going to get sick and injured and die. We have and always will debate how much our society through government, public service agencies, employers and non governmental agencies should provide for our citizens and how much they should provide for themselves. It's a question of opportunities and outcomes. And nobody can completely guarantee outcomes. Freedom of choice will continue to be an issue. People will continue to do things that aren't in their best interests. And to some degree we have to allow them to do them. Even if it hurts us to watch them harm themselves. And patients will come looking for miracle cures. Cures free of burdens on their time, financial resources, pain and discomfort. There will always be those who try to manipulate these human failings. How strictly do we regulate these wonder cures? And when can physicians withhold services if they don't think it is in the best interest of the patient?Humans have and always will get sick injured and die. But once medical interventions were offered we introduced liabilities. You were sick and dying when you came in. I prescribed a series of painful and expensive treatments and you are still sick and dying. Maybe to a lesser degree. But now the healthcare system and the government that provides the system is liable for your sickness, suffering and expenses. Doubly so if the condition was made worse.We have tough questions to deal with.

Sergey Zhukovsky: I am not a health care professional and what's below is just my humble opinion on the topic.\nI was very impressed by the Dr. Martin performance at the US Senate committee. Bravo!\nAt the same time I am somewhat skeptical about her “6 big ideas” on improving Canadian Health care system. \n\nBig Idea 1: The return to relationships: Ensure relationship-based primary health care for every Canadian. \nI don't see this as a new idea. Personally, I always had the same family physician who knows everything about my health problems and follows thoroughly with the treatments I have. \n\nBig Idea 2: A nation with a drug problem: Bring prescription drugs under Medicare. \nWouldn't it be great to have universal prescription drugs and, by the way, dental care coverage for everybody?? Of course it would be great! But how realistic is this proposition at the time of galloping health care cost increases at the average annual rate of 7.4% driving the provincial budgets into the wall. If only money grows on trees… \n\nBig Idea 3: Don't just do something, stand there: Reduce unnecessary tests and interventions.\nThere is very little incentive for the doctors to say “no” to unnecessary tests and interventions in the system where the tests and interventions are “free” for both patients and the doctors. If a patient had to pay a small part of the cost he or she would think twice whether he needs it or not. However, I guess the majority of Canadians will be strongly against charging a patient. \n\nBig Idea 4: Doing more with less: Reorganize health care delivery to reduce wait times and improve quality. It also sounds very nice but isn't it exactly what our provincial governments continuously trying to do with a very uneven success? \n\nBig Idea 5: Basic income for basic health: Implement a basic income guarantee. \nIf only money grows on trees, won't it be great to give free money for everybody?? But unfortunately it is not the case. Firstly, how is it honest and fair to tax hardworking people even more and give free money to those who do nothing? Just to save some money on health care? And secondly, if the federal government provides every adult Canadian with a guaranteed basic income of $15,000 a year and every child with $5,000 the cost of the program will be roughly $450 billion. The total federal revenue is currently less than $300 billion. Ah! If only money grows on trees…\n\nBig Idea 6: The anatomy of change: Scale up successful solutions across the country.\nOur health care system is a pure monopoly and the lack of competition makes it hard to improve.

Eason: Very interesting ideas, Dr. Martin is a truly inspiring leader. I truly hope that these ideas will be implemented one day!!

מתן יבגי: i liked the video because her passion is very much needed for the understanding that not all doctors are good people who do the most for their jobs.. the only way to transform them to be better at their job is by providing inceptive by use of competition

chipette: Whoa she's half Middle Eastern/Arab? :O

SilvanaDil: It's undeniable that wait times for "elective" (ha!) surgeries are very long in Canada.\nNeed a knee replacement, ma'am? You can wait 2-3 years (in pain, limited mobility).\nViagra not working, sir? You can wait 2-3 years for a penile implant. (No sex for you!)

Catherine Radke: I read a news article and you were discussing the risk of seizures. Their was a plan but it was dropped. Many did not survive living alone. I do agree however that you have to know how to utilize the services. I can tell you that I had a stroke and almost died from the tremendous care. Now I am a survivor and will help any way I can from home.\nVOLUNTEERS (ONE WORD) NEXT (COMMUNITY INVOLVEMENT) Every one should be aware of the types of care that is required during an emergency. Thank you for your honesty.

SilvanaDil: Of course, she wants less imaging. The American population is 9x Canada's, but the number of MRI machines in the U.S. is 45x Canada's. Do Americans overuse? Sure, but underuse is no virtue either.

Vinnie M: She has good ideas, but why would you know my countries stats on who dies waiting, and not your own?

miel: Vinnie M because she's well read and they are no data of Canadian dying due to long wait times. Blame Harvard for doing that research and pusblishing it. You wish you had our health care.